Japan FFRangio Clinical Outcomes Study

Active, not recruitingOBSERVATIONAL
Enrollment

2,500

Participants

Timeline

Start Date

November 7, 2022

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2027

Conditions
Coronary Artery Disease
Interventions
OTHER

FFRangio

Assessing the physiologic significance of an intermediate coronary lesion/lesions using FFRangio - a non invasive method to calculate the fractional flow reserve (FFR) of the assessed lesion.

Trial Locations (1)

4941492

Rabin Medical Centre, Petah Tikva

All Listed Sponsors
collaborator

Gifu Heart Center

OTHER

collaborator

Fukuoka Sanno Hospital

UNKNOWN

collaborator

Saga-ken Medical Center Koseikan

UNKNOWN

collaborator

Sakakibara Heart Institute

OTHER

collaborator

Fukuyama Cardiovascular Hospital

UNKNOWN

collaborator

Ichinomiya-Nishi Hospital

UNKNOWN

lead

Rabin Medical Center

OTHER